Association between Hemodynamically Significant Patent Ductus Arteriosus and Bronchopulmonary Dysplasia

Federico Schena1, Gaia Francescato1, Alessia Cappelleri1

  • 1Neonatology and Neonatal Intensive Care Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

Insights

The duration and severity of a patent ductus arteriosus (PDA) shunt in premature infants are linked to increased risks of bronchopulmonary dysplasia (BPD) or death. A standardized PDA staging system aids in evaluating this association and guiding treatment.

Area of Science:

  • Neonatalogy
  • Pediatric Cardiology
  • Respiratory Medicine

Background:

  • Patent ductus arteriosus (PDA) is common in preterm infants and can lead to significant morbidities.
  • The relationship between PDA shunt characteristics and outcomes like bronchopulmonary dysplasia (BPD) requires further clarification.

Purpose of the Study:

  • To investigate the association between the duration and magnitude of PDA shunt and the incidence of BPD or death in preterm infants.
  • To evaluate the utility of a standardized PDA staging system in assessing PDA-related morbidities.

Main Methods:

  • Retrospective analysis of 242 infants born at ≤ 28 weeks gestational age between 2007 and 2012.
  • Echocardiographic evaluations were reviewed to assess PDA presence and severity using the McNamara and Sehgal PDA staging system.
  • Infants were divided into groups based on the development of BPD or death.

Main Results:

  • Infants who developed BPD or died had hemodynamically significant PDA (E3/E4) for a longer duration (4.8 days) compared to those who did not (2.3 days).
  • Each week of a hemodynamically significant PDA increased the risk of BPD (OR 1.7); persistence of a non-significant PDA (E2) was not associated with BPD.
  • Surgical ligation of PDA was not an independent risk factor, but later ligation and prolonged PDA duration were associated with BPD or death.

Conclusions:

  • A standardized PDA staging system is valuable for evaluating PDA morbidities and comparing research.
  • The duration and severity of hemodynamically significant PDA are critical factors associated with BPD or death in preterm infants.
  • This scoring system can assist in guiding clinical management decisions for PDA in neonates.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
886
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
2.1K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.2K